PulseExploreJournal ClubDebatesTrendingResearchersJournals
Instagram
HomeExploreJournal ClubTrending
Synapse
⌘+K
Synapse
April 17, 2026Movement Disorders0 citations

Automating Subthalamic Deep Brain Stimulation Programming with Evoked Resonant Neural Activity in Parkinson's Disease

View Full Paper
KNKanae J. NagaoTPThushara PereraMPMatthew Petoe

Key Points

  • This research aims to assess the feasibility and motor benefits of deep brain stimulation programming based on evoked resonant neural activity in Parkinson's Disease.
  • Assessed 12 patients with well-placed leads 4–6 months post-STN-DBS
  • Tested the worst hemibody off-medication
  • Conducted double-blind assessments across three programming methods: clinician settings, imaging-guided, and ERNA algorithm
  • ERNA programming improved motor scores by 75.7% compared to off-stimulation
  • No significant difference in benefits between ERNA, imaging (81.6%), and clinician programming (68.8%)
  • Therapeutic and side effect thresholds were consistent across all programming methods

Abstract

Abstract Background Optimal outcomes from subthalamic nucleus deep brain stimulation (STN‐DBS) for Parkinson's disease (PD) depend on accurate stimulation of an ideal functional target within the dorsolateral STN. Clinical programming is heuristic, and objective methods are needed to improve efficiency and consistency. Objectives This study aimed to investigate the feasibility and acute motor benefit of STN‐DBS programming, guided by intraoperatively recorded evoked resonant neural activity (ERNA) in patients with PD. Methods We assessed 12 patients with anatomically well‐placed leads, 4–6 months following STN‐DBS. The worst hemibody was tested off‐medication. Acute motor benefit was double‐blind assessed for three programming configurations: (i) chronic expert clinician settings, (ii) imaging guided, and (iii) an ERNA automated algorithm. We also compared therapeutic and side effect thresholds and the spatial distribution of fractionated current. Results ERNA programming improved hemibody Movement Disorder Society‐Unified Parkinson's Disease Rating Scale‐Part III scores by 75.7% (median) compared with off‐stimulation. This was not different from imaging (81.6%, P = 0.19) or clinician programming (68.8%, P = 0.33). Therapeutic thresholds ( P = 0.90) and side effect thresholds ( P = 0.57) did not differ across conditions. ERNA programming was 0.8–1 mm ventral and 0.3 mm posterior to imaging and clinician programming. Conclusions A programming algorithm based solely on ERNA achieved acute motor efficacy and tolerability equivalent to expert clinical and imaging‐based approaches. ERNA recordings took <1 min, under awake and general anesthetic conditions. These findings suggest that intraoperative ERNA can provide a rapid, objective, and practical starting point for STN‐DBS programming. © 2026 The Author(s). Movement Disorders published by Wiley Periodicals LLC on behalf of International Parkinson and Movement Disorder Society.

Ask AI
Helpful
Bookmark
Share
View Full Paper

Cite This Study

Nagao et al. (2026) studied this question.

synapsesocial.com/papers/69e1ce605cdc762e9d85765fhttps://doi.org/10.1002/mds.70318
Ask AI
Helpful
Bookmark
Share
View Full Paper